Kedrion Biopharma rachète 200 M€ de ses titres de dette qui arrivent à échéance en 2022 ...Middle East

Selon le président exécutif Paolo Marcucci : « Nous sommes prêts pour la croissance internationale » LUCQUES, Italie, 2 mai 2022 /PRNewswire/ -- Kedrion Biopharma, le groupe biopharmaceutique italien, a racheté 200 millions d'euros de ses titres de dette, un peu moins de trois mois avant...

Hence then, the article about kedrion biopharma rachete 200 m de ses titres de dette qui arrivent a echeance en 2022 was published today ( Monday 02/05/2022 - 11:42 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Kedrion Biopharma rachète 200 M€ de ses titres de dette qui arrivent à échéance en 2022 )

Also on site :

• Judge Rules That ICE Agents Violate the Fourth Amendment by Making Arrests While Masked
• Glenn Powell Is Expanding His Smash Kitchen Line With a Tasty New Item and Fans Say It's 'Actually the Best'
• Lauren Chapin, the Youngest Kid on ‘Father Knows Best,’ Dies at 80